Hemoglobin Stability in Patients With Anemia, CKD, and Type 2 Diabetes: An Analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) Placebo Arm — Hicham Skali (2012) | RDL Network
Hemoglobin Stability in Patients With Anemia, CKD, and Type 2 Diabetes: An Analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) Placebo Arm
Hicham Skali, Julie Lin, Marc A. Pfeffer, Chaoyin Chen, Mark E. Cooper, John J.V. McMurray, Allen R. Nissenson, Giuseppe Remuzzi, Patrick S. Parfrey, Nairne Scott‐Douglas, Ajay Singh
Marc A. Pfeffer, Emmanuel A. Burdmann, Chao-Yin Chen, Mark E. Cooper, Dick de Zeeuw, Kai‐Uwe Eckardt, Peter Ivanovich, Reshma Kewalramani, Andrew S. Levey, Eldrin F. Lewis, Janet B. McGill, John J.V. McMurray, Patrick S. Parfrey, Hans‐Henrik Parving, Giuseppe Remuzzi, Ajay Singh, Scott D. Solomon, Robert D. Toto, Hajime Uno
Finnian R. Mc Causland, Brian Claggett, Emmanuel A. Burdmann, Glenn M. Chertow, Mark E. Cooper, Kai‐Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis, Janet B. McGill, John J.V. McMurray, Patrick S. Parfrey, Hans‐Henrik Parving, Giuseppe Remuzzi, Ajay Singh, Scott D. Solomon, Robert D. Toto, Marc A. Pfeffer
T.-Christian H. Mix, Robert Brenner, Mark E. Cooper, Dick de Zeeuw, Peter Ivanovich, Andrew S. Levey, Janet B. McGill, John J.V. McMurray, Patrick S. Parfrey, Hans‐Henrik Parving, Brian J.G. Pereira, Giuseppe Remuzzi, Ajay Singh, Scott D. Solomon, Catherine Stehman‐Breen, Robert D. Toto, Marc A. Pfeffer
Finnian R. Mc Causland, Brian Claggett, Emmanuel A. Burdmann, Kai‐Uwe Eckardt, Reshma Kewalramani, Andrew S. Levey, John J.V. McMurray, Patrick S. Parfrey, Giuseppe Remuzzi, Ajay Singh, Scott D. Solomon, Robert D. Toto, Marc A. Pfeffer
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.